Dr. Saad Khan, MD
Claim this profileStanford University
Studies Thyroid Cancer
Studies Thyroid Carcinoma
5 reported clinical trials
5 drugs studied
Area of expertise
1Thyroid Cancer
Stage IV
BRAF negative
Stage III
2Thyroid Carcinoma
Stage IV
BRAF negative
Stage III
Affiliated Hospitals
Clinical Trials Saad Khan, MD is currently running
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies (NSCLC)
Recruiting1 award Phase 1 & 2
Pembrolizumab
for Thyroid Cancer
This is a single-arm, open-label trial designed to evaluate the activity of pembrolizumab therapy in anaplastic thyroid cancer in patients with no curative alternative therapy. Pembrolizumab (Keytruda-Merck) 200 mg, given IV every 3 weeks, until evidence of progression, intolerance of treatment, withdrawal of consent or death
Recruiting1 award Phase 28 criteria
More about Saad Khan, MD
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Saad Khan, MD has experience with
- Pembrolizumab
- EP0031
- Panitumumab
- 89Zr-panitumumab IV
- Abemaciclib
Breakdown of trials Saad Khan, MD has run
Thyroid Cancer
Thyroid Carcinoma
Non-Small Cell Lung Cancer
Solid Tumors
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Saad Khan, MD specialize in?
Saad Khan, MD focuses on Thyroid Cancer and Thyroid Carcinoma. In particular, much of their work with Thyroid Cancer has involved Stage IV patients, or patients who are BRAF negative.
Is Saad Khan, MD currently recruiting for clinical trials?
Yes, Saad Khan, MD is currently recruiting for 2 clinical trials in Stanford California. If you're interested in participating, you should apply.
Are there any treatments that Saad Khan, MD has studied deeply?
Yes, Saad Khan, MD has studied treatments such as Pembrolizumab, EP0031, Panitumumab.
What is the best way to schedule an appointment with Saad Khan, MD?
Apply for one of the trials that Saad Khan, MD is conducting.
What is the office address of Saad Khan, MD?
The office of Saad Khan, MD is located at: Stanford University, Stanford, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.